HCPCS Level II Code Lookup
Look up official HCPCS Level II codes for products, supplies, drugs, equipment and services, or browse by letter family below.
- Current release
- October 2026 effective October 1, 2026
- Active codes
- 7,448 active codes
- Maintainer
- Maintained by CMS
Browse by Letter Family
8,769 codes, grouped by their leading letter.
Q
- Q5122 Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
- Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
- Q5124 Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg
- Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
- Q5126 Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
- Q5127 Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg
- Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
- Q5129 Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg
- Q5130 Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
- Q5131 Injection, adalimumab-aacf (idacio), biosimilar, 20 mg Historical
- Q5132 Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg Historical
- Q5133 Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg
- Q5134 Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg
- Q5135 Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg
- Q5136 Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg
- Q5137 Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg
- Q5138 Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg
- Q5139 Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg Historical
- Q5140 Injection, adalimumab-fkjp, biosimilar, 1 mg
- Q5141 Injection, adalimumab-aaty, biosimilar, 1 mg
- Q5142 Injection, adalimumab-ryvk biosimilar, 1 mg
- Q5143 Injection, adalimumab-adbm, biosimilar, 1 mg
- Q5144 Injection, adalimumab-aacf (idacio), biosimilar, 1 mg
- Q5145 Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg
- Q5146 Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg
- Q5147 Injection, aflibercept-ayyh (pavblu), biosimilar, 1 mg
- Q5148 Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram
- Q5149 Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg
- Q5150 Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg
- Q5151 Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg
- Q5152 Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg
- Q5153 Injection, aflibercept-yszy (opuviz), biosimilar, 1 mg
- Q5154 Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg
- Q5155 Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg
- Q5156 Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg
- Q5157 Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mg
- Q5158 Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg
- Q5159 Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg
- Q5160 Injection, bevacizumab-nwgd (jobevne), biosimilar, 10 mg
- Q5161 Injection, denosumab-kyqq (aukelso/bosaya), biosimilar, 1 mg
- Q5162 Injection, denosumab-nxxp (bildyos/bilprevda), biosimilar, 1 mg
- Q5164 Injection, ustekinumab-hmny (starjemza), biosimilar, 1 mg
- Q5165 Injection, denosumab-mobz (oziltus), biosimilar, 1 mg
- Q5166 Injection, denosumab-desu (osvyrti/jubereq), biosimilar, 1 mg
- Q5167 Injection, denosumab-qbde (enoby/xtrenbo), biosimilar, 1 mg
- Q5168 Injection, ranibizumab-leyk (nufymco), biosimilar, 0.1 mg
- Q5169 Injection, pegfilgrastim-unne (armlupeg), biosimilar, 0.5 mg
- Q5170 Injection, aflibercept-boav (eydenzelt), biosimilar, 1 mg
- Q5171 Injection, denosumab-mobz (boncresa), biosimilar, 1 mg
- Q5172 Injection, filgrastim-laha (filkri), biosimilar, 1 microgram
- Q5173 Injection, denosumab-adet (ponlimsi), biosimilar, 1 mg
- Q9001 Assessment by chaplain services
- Q9002 Counseling, individual, by chaplain services
- Q9003 Counseling, group, by chaplain services
- Q9004 Department of veterans affairs whole health partner services
- Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml
- Q9951 Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
- Q9953 Injection, iron-based magnetic resonance contrast agent, per ml
- Q9954 Oral magnetic resonance contrast agent, per 100 ml
- Q9955 Injection, perflexane lipid microspheres, per ml
- Q9956 Injection, octafluoropropane microspheres, per ml
- Q9957 Injection, perflutren lipid microspheres, per ml
- Q9958 High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
- Q9959 High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
- Q9960 High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
- Q9961 High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
- Q9962 High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
- Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
- Q9964 High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
- Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
- Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
- Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
- Q9968 Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
- Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose Historical
- Q9970 Injection, ferric carboxymaltose, 1mg Historical
- Q9972 Injection, epoetin beta, 1 microgram, (for esrd on dialysis) Historical
- Q9973 Injection, epoetin beta, 1 microgram, (non-esrd use) Historical
- Q9974 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg Historical
- Q9975 Injection, factor viii fc fusion protein (recombinant), per iu Historical
- Q9976 Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron Historical
- Q9977 Compounded drug, not otherwise classified Historical
- Q9978 Netupitant 300 mg and palonosetron 0.5 mg Historical
- Q9979 Injection, alemtuzumab, 1 mg Historical
- Q9980 Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg Historical
- Q9981 Rolapitant, oral, 1 mg Historical
- Q9982 Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
- Q9983 Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
- Q9984 Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg Historical
- Q9985 Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg Historical
- Q9986 Injection, hydroxyprogesterone caproate, (makena), 10 mg Historical
- Q9987 Pathogen(s) test for platelets Historical
- Q9988 Platelets, pheresis, pathogen-reduced, each unit Historical
- Q9989 Ustekinumab, for intravenous injection, 1 mg Historical
- Q9991 Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
- Q9992 Injection, buprenorphine extended-release (sublocade), greater than 100 mg
- Q9993 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg Historical
- Q9994 In-line cartridge containing digestive enzyme(s) for enteral feeding, each Historical
- Q9995 Injection, emicizumab-kxwh, 0.5 mg Historical
- Q9996 Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg
- Q9997 Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg